Combined high-sensitivity copeptin and troponin T evaluation for the diagnosis of non-ST elevation acute coronary syndrome in the emergency department

Aitor Alquézar, Miguel Santaló, Miguel Rizzi, Ignasi Gich, Margarita Grau, Alessandro Sionis, Jordi Ordóñez-Llanos, Javier Mercé, Alfonso Martin, Mar Muñoz, Javier Povar, Joaquín Velilla, Pilar Calmarza, Francisco Temboury, Carmen Ortiz, José Balaguer, Arturo Carratalá

Research output: Contribution to journalArticleResearchpeer-review

8 Citations (Scopus)


© 2017, Grupo Saned. All rights reserved. Objectives. To assess the diagnostic yield of a high-sensitivity copeptin (hs-copep) assay alone or in combination with a high-sensitivity cardiac troponin T (hs-cTnt) assay for the diagnosis of non-ST segment elevation acute coronary syndrome (NSTEMI) in patients with chest pain in the emergency department (ED). The secondary aim was to assess the 1-year prognostic utility of these biomarkers in this clinical context. Material and methods. Retrospective observational study of a series of patients attended for chest pain suggesting myocardial ischemia in 5 Spanish ED. The first blood drawn in the ED was used for hs-copep and hs-cTnt assays, which were processed in a single laboratory serving all centers. Diagnostic utility was assessed by sensitivity, specificity, positive and negative predictive values and likelihood ratios, and the area under the receiver operating characteristic curve (ROC). We also performed a separate analysis with data for the subgroup of patients with early detection of symptoms (3 h of onset of symptoms). We recorded complications, mortality or reinfarction occurring within a year of the index event. Results. We included 297 patients; 63 (21.2%) with NSTEMI. The median age was 69 years (interquartile range, 70–76 years), and 199 (67%) were men. The ROC was 0.89 (95% CI, 0.85–0.94) for the hs-cTnt assay, 0.58 (95% CI, 0.51–0.66) for the hs-copep assay, and 0.90 (95% CI, 0.86–0.94) for the 2 assays combined. The ROC for the 2 assays combined was not significantly better than the ROC for the hs-cTnt by itself (P=.89). We saw the same pattern of results when we analyzed the subgroup of patients who presented early. Sixty percent of the complications occurred in patients with elevated findings on both assays. Elevated hs-copep findings did not provide prognostic information that was not already provided by hs-cTnt findings (P=.56). Conclusion. The hs-copep assay does not increase the diagnostic or prognostic yield already provided by the hs-cTnt assay in patients suspected of myocardial infarction in the ED.
Original languageEnglish
Pages (from-to)237-244
Issue number4
Publication statusPublished - 1 Jan 2017


  • Acute myocardial infarction
  • Diagnosis
  • High-sensitivity cardiac troponin T assay
  • High-sensitivity copeptin
  • Prognosis


Dive into the research topics of 'Combined high-sensitivity copeptin and troponin T evaluation for the diagnosis of non-ST elevation acute coronary syndrome in the emergency department'. Together they form a unique fingerprint.

Cite this